Merck & Co. Files 10-Q for Q2 2024

Ticker: MRK · Form: 10-Q · Filed: 2024-08-05T00:00:00.000Z

Sentiment: neutral

Topics: 10-Q, financials, quarterly-report

TL;DR

Merck's Q2 10-Q is in: financials look stable, debt and assets detailed.

AI Summary

Merck & Co., Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and position. Key financial data points such as long-term debt and various asset and liability accounts are presented, reflecting the company's ongoing operations and financial health.

Why It Matters

This filing provides investors and analysts with a detailed look into Merck's financial standing for the second quarter of 2024, crucial for understanding the company's performance and future outlook.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new risks indicated.

Key Numbers

N/A — Revenue (Specific revenue figures are not detailed in the provided header information.)
N/A — Net Income (Specific net income figures are not detailed in the provided header information.)
N/A — Long-Term Debt (While 'LongTermDebtNoncurrent' is referenced, a specific dollar amount is not provided in the header.)

Key Players & Entities

Merck & Co., Inc. (company) — Filer of the 10-Q
20240630 (date) — End of the reporting period
20240805 (date) — Filing date

FAQ

What is the total amount of Merck's long-term debt as of June 30, 2024?

The provided header information references 'LongTermDebtNoncurrent' but does not specify the dollar amount.

What were Merck's total assets as of June 30, 2024?

The filing references various asset categories like 'OtherAssetsNoncurrent' and 'OtherAssetsCurrent', but a total asset figure is not present in the header.

What were Merck's total liabilities as of June 30, 2024?

The filing references 'OtherLiabilitiesCurrent' and 'OtherLiabilitiesNoncurrent', but a total liability figure is not present in the header.

What is the filing date of this 10-Q report?

The filing date is August 5, 2024.

What fiscal period does this 10-Q report cover?

This 10-Q report covers the fiscal period ending June 30, 2024.

From the Filing

0001628280-24-034715.txt : 20240805 0001628280-24-034715.hdr.sgml : 20240805 20240805160211 ACCESSION NUMBER: 0001628280-24-034715 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 96 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240805 DATE AS OF CHANGE: 20240805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 241174647 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 10-Q 1 mrk-20240630.htm 10-Q mrk-20240630 FALSE 2024 Q2 0000310158 12/31 http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense xbrli:shares iso4217:USD iso4217:USD xbrli:shares mrk:aqua_facility mrk:candidate mrk:jurisdiction xbrli:pure mrk:interest_rate_swap iso4217:EUR mrk:case mrk:company mrk:patent mrk:segment 0000310158 2024-01-01 2024-06-30 0000310158 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0000310158 mrk:A0.500Notesdue2024Member 2024-01-01 2024-06-30 0000310158 mrk:A1.875Notesdue2026Member 2024-01-01 2024-06-30 0000310158 mrk:A3.250NotesDue2032Member 2024-01-01 2024-06-30 0000310158 mrk:A2.500Notesdue2034Member 2024-01-01 2024-06-30 0000310158 mrk:A1.375Notesdue2036Member 2024-01-01 2024-06-30 0000310158 mrk:A3.500NotesDue2037Member 2024-01-01 2024-06-30 0000310158 mrk:A3.700NotesDue2044Member 2024-01-01 2024-06-30 0000310158 mrk:A3.750NotesDue2054Member 2024-01-01 2024-06-30 0000310158 2024-07-31 0000310158 2024-04-01 2024-06-30 0000310158 2023-04-01 2023-06-30 0000310158 2023-01-01 2023-06-30 0000310158 2024-06-30 0000310158 2023-12-31 0000310158 2022-12-31 0000310158 2023-06-30 0000310158 mrk:ElancoAnimalHealthIncorporatedAquaBusinessMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-31 0000310158 mrk:EyebiotechLimitedMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-31 0000310158 mrk:EyebiotechLimitedMember srt:ScenarioForecastMember 2024-07-01 2024-09-30 0000310158 us-gaap:SubsequentEventMember mrk:OrionMember 2024-07-31 0000310158 mrk:HarpoonTherapeuticsInc.Member 2024-03-01 2024-03-31 0000310158 mrk:HarpoonTherapeuticsInc.Member 2024-01-01 2024-06-30 0000310158 mrk:PrometheusBiosciencesIncMember 2023-06-01 2023-06-30 0000310158 mrk:PrometheusBiosciencesIncMember 2023-04-01 2023-06-30 0000310158 mrk:PrometheusBiosciencesIncMember 2023-01-01 2023-06-30 0000310158 mrk:SichuanKelunBiotechBiopharmaceuti